Stockreport

Reneo stockholders approve merger with OnKure [Seeking Alpha]

Reneo Pharmaceuticals, Inc. - Class A  (RPHM) 
PDF OnKure is a clinical-stage biopharmaceutical company focused on the discovery and development of best-in-class precision medicines. The closing of the merger is antic [Read more]